A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML); Cancer Interventions: Drug: Venetoclax; Drug: Azacitidine; Other: Best Supportive Care (BSC) Sponsor: AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Leukemia | Research | Stem Cell Therapy | Stem Cells | Study | Transplants